Background Approximately 95% of patients with idiopathic nephrotic syndrome (INS) have a favorable prognosis, though 4–5% progress to end-stage renal disease. The recurrence rate of INS following kidney transplantation is approximately 30%.
Ryoichi Miyazaki +9 more
doaj +1 more source
Exploring novel pathways and potential therapeutic targets for diabetic nephropathy: The interplay of podocytes and proximal tubular epithelial cells. [PDF]
Abdelaziz TS.
europepmc +1 more source
Slit Diaphragm Molecular Changes in Recurrent FSGS With Antinephrin Autoantibodies. [PDF]
Shirai Y +7 more
europepmc +1 more source
Collapsing Focal Segmental Glomerulosclerosis With Anti-nephrin Antibody Following Minimal Change Disease Possibly Triggered by COVID-19 Infection: A Case Report. [PDF]
Oguchi H +9 more
europepmc +1 more source
MicroRNA21/HDAC4 mediates podocyte apoptosis under high glucose conditions by regulating the activation of FoxO1. [PDF]
Fu L +6 more
europepmc +1 more source
Utility of different anti-IgG antibodies in recognition of punctate (powdery) podocyte staining by immunofluorescence in patients with diffuse podocyte foot process effacement. [PDF]
Dasgupta A +5 more
europepmc +1 more source
New Ways of Thinking about Proteinuria and Progression of Renal Damage [PDF]
Turner, Neil, Zhou, Y. S.
core +1 more source
The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes. [PDF]
Li C +5 more
europepmc +1 more source

